Spire Healthcare Group Plc (LSE:SPI) — Market Cap & Net Worth
Market Cap & Net Worth: Spire Healthcare Group Plc (SPI)
Spire Healthcare Group Plc (LSE:SPI) has a market capitalization of $8.05 Million (GBX66.15 Billion) as of May 4, 2026. Listed on the LSE stock exchange, this UK-based company holds position #27391 globally and #380 in its home market, demonstrating a -0.36% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Spire Healthcare Group Plc's stock price GBX164.40 by its total outstanding shares 402371415 (402.37 Million). Analyse Spire Healthcare Group Plc (SPI) cash conversion ratio to see how efficiently the company converts income to cash.
Spire Healthcare Group Plc Market Cap History: 2015 to 2026
Spire Healthcare Group Plc's market capitalization history from 2015 to 2026. Data shows change from $13.68 Million to $8.05 Million (-6.62% CAGR).
Index Memberships
Spire Healthcare Group Plc is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE All-Share
FTAS
|
$62.11 Billion | 0.01% | #280 of 573 |
|
FTSE 350
FTLC
|
$61.53 Billion | 0.01% | #265 of 350 |
|
FTSE 250
FTMC
|
$8.75 Billion | 0.09% | #180 of 250 |
|
FTSE 350 Health Care Equipment & Services
NMX4530
|
$176.34 Million | 4.56% | #3 of 3 |
Weight: Spire Healthcare Group Plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Spire Healthcare Group Plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Spire Healthcare Group Plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Spire Healthcare Group Plc's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.44x
Spire Healthcare Group Plc's market cap is 0.44 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $13.68 Million | $884.80 Million | $60.00 Million | 0.02x | 0.23x |
| 2016 | $14.92 Million | $926.40 Million | $53.60 Million | 0.02x | 0.28x |
| 2017 | $11.33 Million | $931.70 Million | $16.80 Million | 0.01x | 0.67x |
| 2018 | $4.97 Million | $931.10 Million | $100.00K | 0.01x | 49.67x |
| 2019 | $6.69 Million | $980.80 Million | $7.20 Million | 0.01x | 0.93x |
| 2020 | $7.53 Million | $919.90 Million | -$233.90 Million | 0.01x | N/A |
| 2021 | $12.12 Million | $1.11 Billion | -$9.70 Million | 0.01x | N/A |
| 2022 | $11.05 Million | $1.20 Billion | $8.60 Million | 0.01x | 1.28x |
| 2023 | $11.00 Million | $1.36 Billion | $27.30 Million | 0.01x | 0.40x |
| 2024 | $11.06 Million | $1.51 Billion | $25.40 Million | 0.01x | 0.44x |
Competitor Companies of SPI by Market Capitalization
Companies near Spire Healthcare Group Plc in the global market cap rankings as of May 4, 2026.
Key companies related to Spire Healthcare Group Plc by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #256 globally with a market cap of $96.85 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #962 globally with a market cap of $27.16 Billion USD ( €23.23 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #972 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1292 globally with a market cap of $19.57 Billion USD ( RM77.93 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #256 | HCA Holdings Inc | NYSE:HCA | $96.85 Billion | $433.09 |
| #962 | Fresenius SE & Co. KGaA | XETRA:FRE | $27.16 Billion | €41.25 |
| #972 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1292 | IHH Healthcare Bhd | KLSE:5225 | $19.57 Billion | RM8.82 |
Spire Healthcare Group Plc Historical Marketcap From 2015 to 2026
Between 2015 and today, Spire Healthcare Group Plc's market cap moved from $13.68 Million to $ 8.05 Million, with a yearly change of -6.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX8.05 Million | -1.56% |
| 2025 | GBX8.18 Million | -26.11% |
| 2024 | GBX11.06 Million | +0.57% |
| 2023 | GBX11.00 Million | -0.44% |
| 2022 | GBX11.05 Million | -8.80% |
| 2021 | GBX12.12 Million | +60.88% |
| 2020 | GBX7.53 Million | +12.55% |
| 2019 | GBX6.69 Million | +34.72% |
| 2018 | GBX4.97 Million | -56.17% |
| 2017 | GBX11.33 Million | -24.02% |
| 2016 | GBX14.92 Million | +9.05% |
| 2015 | GBX13.68 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Spire Healthcare Group Plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.05 Million USD |
| MoneyControl | $8.05 Million USD |
| MarketWatch | $8.05 Million USD |
| marketcap.company | $8.05 Million USD |
| Reuters | $8.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Spire Healthcare Group Plc
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. The company operates in three segments: Hospitals Business, Vita Health Group, and The Doctors Clinic Group. It provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general su… Read more